| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |